3D Doppler ultrasound accurately identifies cancerous tumors

Article

Three-dimensional (3D) power Doppler ultrasound helps differentiate malignant and benign breast lesions, according to a report in the November issue of Radiology.

Three-dimensional (3D) power Doppler ultrasound helps differentiate malignant and benign breast lesions, according to a report in the November issue of Radiology.

Gerald L. LeCarpentier, PhD, of the University of Michigan in Ann Arbor, and colleagues examined the usefulness of a 3D Doppler ultrasound exam to distinguish benign and malignant lesions among women scheduled for a core or excisional biopsy of the breast due to a suspicious breast mass.

Overall, 78 women between the ages of 26 and 70 had the 3D ultrasound and were biopsied. 3D Doppler ultrasound had a sensitivity of 100% in identifying malignant tumors and a specificity of 86% in excluding benign tumors when used in combination with age-based assessment and gray scale visual analysis, the researchers report.

“Using 3D scans promises greater accuracy due to more consistent sampling over the entire tumor,” said LeCarpentier in a statement. “Using speed-weighted 3D power Doppler ultrasound, higher flow velocities in the malignant tumor-feeding vessels may be detected, whereas vessels with slower flow velocities in surrounding benign masses may be excluded.”

LeCarpentier GL, Roubidoux MA, Fowlkes JB, et al. Suspicious breast lesions: assessment of 3D Doppler US indexes for classification in a test population and fourfold cross-validation scheme. Radiology. 2008;249:463-470. DOI:10.1148/radiol.2492060888.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Haluk Damgacioglu, PhD, discusses cervical cancer's link to anal cancer risk | Image Credit: cadsci.com.
Natalia Llarena, MD, discusses rising fertility anxiety in Gen Z | Image Credit: havingbabies.com.
Uma Mahadevan, MD, highlights new guidelines for managing IBD | Image Credit: ucsfhealth.org.
© 2025 MJH Life Sciences

All rights reserved.